Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Background: Managing Diabetes With Glucose Monitoring and Glycemic Control (2 of 2)
SMBG allows more specific and timely feedback on hyperglycemia and allows patients to evaluate their individual response to therapy. It has been shown to be a component of successful diabetes management.
rt-CGM equipment consists of a transcutaneous glucose sensor that is connected to a transmitter and receiver. Physicians currently recommend rt-CGM for patients with type 1 diabetes who have hypoglycemia unawareness, frequent hypoglycemia where their HbA1c is over the recommended target, or excess glycemic excursions. They also recommend rt-CGM for patients who are in preconception planning or are pregnant.
The challenges of using SMBG include the associated pain, costs, behavioral and technical skills, required motivation, and intrusiveness that affect adherence to this technique. With rt-CGM, success in lowering blood glucose levels depends on adherence to ongoing use of the device.
Abbreviations: HbA1c = hemoglobin A1c; rt-CGM = real-time continuous glucose monitoring; SMBG = self-monitoring of blood glucose
- Golden SH, Brown T, Yeh HC, et al. Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness. Comparative Effectiveness Review No. 57 (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-2007-10061-I). Rockville, MD: Agency for Healthcare Research and Quality; July 2012. AHRQ Publication No. 12-EHC036. Available at www.effectivehealthcare.ahrq.gov/glucose.cfm.
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-9. PMID: 20042775.
- American Diabetes Association. Standards of Medical Care in Diabetes—2012. Diabetes Care 2012;35 Suppl 1:S11-63. PMID: 22187469.
- Blevins TC, Bode BW, Garg SK, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010;16(5):730-45. PMID: 21356637.
- Tamborlane WV, Beck RW, Bode BW, et al. Continuous monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359(14):1464-76. PMID: 18779236.
Your slide tray is being processed.